Insiders · Profile

Rosenblum Mark J

Exec VP Finance, CFO at Decoy Therapeutics. Filing since 13 Feb 2020. CIK 0001329154

Company
Date
Role
Action
Shares
Amount
Of holding
20 Nov 2025
Exec VP Finance, CFO
Bought
20,000
$16.00K
×113
31 May 2022
Exec VP Finance, CFO
Bought
28,000
$5.04K
23.3%
3 Mar 2022
Exec VP Finance, CFO
Bought
76,246
$29.81K
224%
17 Aug 2020
Exec VP Finance, CFO
Bought
5,000
$5.00K
71.4%
19 Feb 2020
Exec VP Finance, CFO
Bought
2,000
$1.90K
40.0%
13 Feb 2020
Exec VP Finance, CFO
Bought
5,000
$4.30K
opened
6 decisions on file.